May 14 2012
|more articles from|
Julphar Lays The Foundation Stone Of Its New Algeria Plant
$32 Million Dollar Investment In New Facility
Algeria 14 May 2012 - Gulf Pharmaceutical Industries ( Julphar ) has laid the foundation stone of its manufacturing plant in Algeria which is being built in partnership with the Algerian Ministry of Health. The new plant, to be known as Albrat, is located in the capital, Algiers, and will be equipped with state-of-the-art technology enabling production of Julphar products for the local market and further beyond into North Africa. Julphar will invest $32 million dollars in the construction of the plant which will be completed in 2014.
During a formal ceremony held in the Algerian capital, Sheikh Ahmed Bin Saqr Al Qasimi, representative of the Julphar Board of Directors, along with the Algerian Minister of Health,H.E.Minister Djamel Ould Abbas and Julphar 's CEO, Dr Ayman Sahli laid the inaugural foundation stone for the plant.
Speaking at the ceremony, HH Sheikh Ahmed Bin Saqr Al Qasimi, commented: 'We are very excited about this partnership with the Algerian Ministry of Health and the formal laying of the foundation stone is a symbol of the excellent relations enjoyed by our two countries.''
He continued: "We can confirm that the laying of the foundation stone for this project is an important step on the path to the establishment of a new phase in the UAE's active participation with Algeria, which is one of the most important markets in North Africa. We are confident that our joint efforts will benefit all the countries of North Africa and provide a secure and safe environment for the production of pharmaceutical products.'
Julphar is a public shareholding company based in Ras Al Khaimah (UAE). It was established in 1980 under the guidance of H H Sheikh Saqr Bin Mohammed Al Qasimi, the Ruler of Ras Al Khaimah, and is currently a leader in the production and distribution of pharmaceutical products in over 50 countries.
Since inception, Julphar remains committed to meeting the needs of an evolving society and playing an instrumental role in global healthcare development. Its approach to a fast paced market is to focus on strategic initiatives, quality product development and ensuring responsible practices.
Julphar 's goal is to create innovative and high-quality products, whilst maintaining a competitive cost. This is achieved through an enhanced organizational structure consisting of ten world-class plants based in the UAE, and a reliable transportation network which covers five continents.
Julphar contains a diverse portfolio of products which targets a large range of major therapeutic segments, including cardiovascular, diabetes, gynecology and other consumer products.
Julphar is well positioned to meet tomorrow's healthcare challenges.
For further information please contact Liz Bamford, The PR Company, 050 551 5971, firstname.lastname@example.org or Samantha Armstrong 050 1582958 email@example.com
© Press Release 2012
© Copyright Zawya. All Rights Reserved.